LNC vs VOR · P/E 4.9, rev $18.21B vs $813.9M cap
Lincoln National Corporation (LNC) versus Vor Biopharma Inc (VOR) — a side-by-side from cached financials, not a winner call.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Vor Biopharma Inc (VOR) is a biotechnology company listed on NASDAQ.
Latest reported LNC revenue for 2025-12-31 was $18.21B. Net income was $1.18B. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
VOR does not have a complete income-statement cache yet.
LNC currently screens at market cap $5.94B and trailing P/E 4.9. VOR currently screens at market cap $813.9M.
Not investment advice. Open the LNC and VOR stock pages for the full models.
Not investment advice.